Page 2256 - Williams Hematology ( PDFDrive )

2230 Part XII: Hemostasis and Thrombosis Chapter 130: Hereditary Thrombophilia 2231

Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol 109. Middeldorp S: Thrombophilia and pregnancy complications: Cause or association? J
Assess 10:1, 2006. Thromb Haemost 5:276, 2007.
93. Bank I, Scavenius MP, Buller HR, Middeldorp S: Social aspects of genetic testing for 110. Rodger MA, Paidas MJ, Mclintock C, et al: Inherited thrombophilia and pregnancy
factor V Leiden mutation in healthy individuals and their importance for daily practice. complications revisited: Association not proven causal and antithrombotic prophylaxis
Thromb Res 113:7, 2004. is experimental. Obstet Gynecol 112:320, 2008.
94. Cohn DM, Vansenne F, Kaptein AA, et al: The psychological impact of testing for 111. de Jong PG, Goddijn M, Middeldorp S: Antithrombotic therapy for pregnancy loss.
thrombophilia: A systematic review. J Thromb Haemost 6:1099, 2008. Hum Reprod Update 19:674, 2013.
95. van Sluis GL, Sohne M, El Kheir DY, et al: Family history and inherited thrombophilia. 112. de Jong PG, Kaandorp SP, Di Nisio M, et al: Aspirin or anticoagulants for treating
J Thromb Haemost 4:2182, 2006. recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Data-
96. Ruff CT, Giugliano RP, Braunwald E, et al: Comparison of the efficacy and safety of new base Syst Rev 7:CD004734, 2014.
oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of 113. Rodger MA, Hague WM, Kingdom J, et al: Antepartum dalteparin versus no antepar-
randomised trials. Lancet 383:955, 2014. tum dalteparin for the prevention of pregnancy complications in pregnant women with
97. van Es N, Coppens M, Schulman S, et al: Direct oral anticoagulants compared with vita- thrombophilia (TIPPS): A multinational open-label randomised trial. Lancet 384:1673,
min K antagonists for acute symptomatic venous thromboembolism: Evidence from 2014.
phase 3 trials. Blood 124:1968, 2014. 114. Gris JC, Mercier E, Quere I, et al: Low-molecular-weight heparin versus low-dose aspi-
98. Bleker SM, Coppens M, Middeldorp S: Sex, thrombosis and inherited thrombophilia. rin in women with one fetal loss and a constitutional thrombophilic disorder. Blood
Blood Rev 28:123, 2014. 103:3695, 2004.
99. Bank I, Libourel EJ, Middeldorp S, et al: High rate of skin complications due to low-mo- 115. Rodger M: Important publication missing key information. Blood 104:3413, 2004.
lecular-weight heparins in pregnant women. J Thromb Haemost 1:859, 2003. 116. de Vries JI, van Pampus MG, Hague WM, et al: Low-molecular-weight heparin added
100. Deruelle P, Denervaud M, Hachulla E, et al: Use of low-molecular-weight heparin from to aspirin in the prevention of recurrent early-onset preeclampsia in women with
the first trimester of pregnancy: A retrospective study of 111 consecutive pregnancies. inheritable thrombophilia: The FRUIT-RCT. J Thromb Haemost 10:64, 2012.
Eur J Obstet Gynecol Reprod Biol 127:73, 2006. 117. Middeldorp S: Thrombosis in women: What are the knowledge gaps in 2013? J Thromb
101. Schindewolf M, Gobst C, Kroll H, et al: High incidence of heparin-induced allergic Haemost 11(Suppl 1):180, 2013.
delayed-type hypersensitivity reactions in pregnancy. J Allergy Clin Immunol 132:131, 118. Ridker PM, Miletich JP, Hennekens CH, Buring JE: Ethnic distribution of factor V Lei-
2013. den in 4047 men and women. Implications for venous thromboembolism screening.
102. Bates SM, Greer IA, Middeldorp S, et al: VTE, thrombophilia, antithrombotic therapy, JAMA 277:1305, 1997.
and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: Ameri- 119. Dilley A, Austin H, Hooper WC, et al: Prevalence of the prothrombin 20210 G-to-A
can College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141 variant in blacks: Infants, patients with venous thrombosis, patients with myocardial
(Suppl 2):e691S, 2012. infarction, and control subjects. J Lab Clin Med 132:452, 1998.
103. Heit JA, Kobbervig CE, James AH, et al: Trends in the incidence of venous thromboem- 120. Simioni P, Sanson BJ, Prandoni P, et al: The incidence of venous thromboembolism in
bolism during pregnancy or postpartum: A 30-year population-based study. Ann Intern families with inherited thrombophilia. Thromb Haemost 81:198, 1999.
Med 143:697, 2005. 121. Middeldorp S, Henkens CMA, Koopman MM, et al: The incidence of venous throm-
104. Middeldorp S: Duration of anticoagulation for venous thromboembolism. BMJ boembolism in family members of patients with factor V Leiden mutation and venous
342:d2758, 2011. thrombosis. Ann Intern Med 128:15, 1998.
105. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working 122. Bank I, Libourel EJ, Middeldorp S, et al: Prothrombin 20210A mutation: A mild risk
Group: Recommendations from the EGAPP Working Group: Routine testing for factor factor for venous thromboembolism but not for arterial thrombotic disease and preg-
V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history nancy-related complications in a family study. Arch Intern Med 164:1932, 2004.
of idiopathic venous thromboembolism and their adult family members. Genet Med 123. Coppens M, van der Poel MH, Bank I, et al: A prospective cohort study on the absolute
13:67, 2011. incidence of venous thromboembolism and arterial cardiovascular disease in asymp-
106. Cohn DM, Vansenne F, de Borgie CA, Middeldorp S: Thrombophilia testing for preven- tomatic carriers of the prothrombin 20210A mutation. Blood 108:2604, 2006.
tion of recurrent venous thromboembolism. Cochrane Database Syst Rev 12:CD007069, 124. Lijfering W, Coppens M, van der Poel MH, et al: The risk of venous and arterial throm-
2009. bosis in hyperhomocysteinemia is low and mainly depends on concomitant throm-
107. Coppens M, Reijnders JH, Middeldorp S, et al: Testing for inherited thrombophilia bophilic defects. Thromb Haemost 98:457, 2007.
does not reduce recurrence of venous thrombosis. J Thromb Haemost 6:1474, 2008. 125. Van de Poel MH, Coppens M, Middeldorp S, et al: Absolute risk of venous and arterial
108. Henderson JT, Whitlock EP, O'Connor E, et al: Low-dose aspirin for prevention of thromboembolism associated with mild hyperhomocysteinemia. results from a retro-
morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. spective family cohort study. J Thromb Haemost 3 (Suppl 1):P0481, 2005.
Preventive Services Task Force. Ann Intern Med 160:695, 2014.

Kaushansky_chapter 130_p2221-2232.indd 2231 9/21/15 4:34 PM